Location · Cooper City, FL
Clinical trials in Cooper City, FL
10 recruiting studies have a site in Cooper City, and 1 of them accept healthy volunteers.
10 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
Eli Lilly and Company
- Location
- Cooper City, FL + 8 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Merck Sharp & Dohme LLC
- Location
- Cooper City, FL + 35 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Vor Biopharma
- Location
- Cooper City, FL + 46 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Takeda
- Location
- Cooper City, FL + 45 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Novartis Pharmaceuticals
- Location
- Cooper City, FL + 20 other US sites
- Eligibility basics
- Ages 12–100
- RecruitingPhase 2
A Study of Brenipatide in Adult Participants With Schizophrenia
Eli Lilly and Company
- Location
- Cooper City, FL + 31 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 3
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
EMD Serono Research & Development Institute, Inc.
- Location
- Cooper City, FL + 11 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
Incyte Corporation
- Location
- Cooper City, FL + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
Fate Therapeutics
- Location
- Cooper City, FL + 11 other US sites
- Eligibility basics
- Ages 12–70
- RecruitingPhase 2
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
Novartis Pharmaceuticals
- Location
- Cooper City, FL + 26 other US sites
- Eligibility basics
- Ages 18–75